Pfizer

Showing 15 posts of 894 posts found.

AstraZeneca completes respiratory deal with Almirall

November 3, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory

AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …

Google image

Google X developing diagnosis pill

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

Viiv image

GSK mulls $27 billion ViiV sell-off

October 23, 2014
Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …

Pfizer breast cancer pill gets FDA nod

October 14, 2014
Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib

Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …

ABPI image

ABPI and BIA establish new manufacturing partnership

September 23, 2014
Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip

The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …

Pfizer image

Pfizer partners with MedGenesis on Parkinson’s

September 16, 2014
Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience

Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …

BMS image

Bristol-Myers Squibb: following the string of pearls

September 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions

Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …

astrazeneca_sign_sky_14

AZ shares climb on positive cancer drug news

September 1, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1

AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …

nricciardi_asterias

Asterias Biotherapeutics adds two to board

August 26, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asterias Biotherapeutics, Pfizer

US biotech firm Asterias Biotherapeutics has confirmed the appointments of Andrew Arno and Natale Ricciardi to its board of directors. …

eliquis image

Pfizer/BMS blood thinner gains new licence

August 22, 2014
Sales and Marketing BMS, DVT, Eliquis, Pfizer, Pradaxa, Xarelto, blood, warfarin

Pfizer and Bristol-Myers Squibb have been handed a much-needed lift after its new blood thinner Eliquis gained a licence extension …

Astrazeneca image

AstraZeneca shores up defences against Pfizer

August 22, 2014
Medical Communications, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, deal, merger

AstraZeneca has been making a series of big deals over the past three months as it looks to close the …

pfizer image

Pfizer teams up with Google-backed 23andMe

August 13, 2014
Research and Development, Sales and Marketing 23andME, Crohn’s disease, Pfizer, google, ulcerative colitis

Pfizer and genetics testing firm 23andMe have come together in a research pact aimed at finding the genetic cause of …

Shire logo

AbbVie/Shire deal under threat from tax laws

August 7, 2014
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion

The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …

abpi_reception

ABPI president: NICE needs political reform

August 1, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, NICE, Pfizer, jonathan emms, vba

Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …

boehringer_angle_22

Boehringer’s Striverdi gains FDA approval

August 1, 2014
Sales and Marketing Advair, COPD, Pfizer, Spiriva, asthma, olodaterol

Boehringer Ingelheim’s new lung drug Striverdi has gained US approval for patients with chronic obstructive pulmonary disorder. Striverdi Respimat (olodaterol), …

The Gateway to Local Adoption Series

Latest content